Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Aggie who wrote (725)	3/11/2000 9:51:00 PM
From: tuck	Respond to of 783

Aggie, I can understand that for someone with a long history in this company, this is a frustrating time. The company is in a transitional phase, heading for pharmahood when it hasn't been fashionable. Go ahead and try to wring some more out of biotech. I will, too. But the biotech rally is usually a seasonal event, and the season is ending. Pharmas are a good contrarian play now, and personally, I think BCHE is doing OK so far. I think pharmas and financials will be the benificiaries of the next rotation, at the expense of all but the most solid techs and biotechs. The time is nigh when companies with profits will be fashionable again ;~} So my HO is that you're leaving at the wrong time, but I can't blame you. Happy Trails, Tuck